Mainz Biomed (MYNZ) to Release Quarterly Earnings on Tuesday

Mainz Biomed (NASDAQ:MYNZ) is expected to be posting its quarterly earnings results before the market opens on Tuesday, July 1st. Analysts expect Mainz Biomed to post earnings of ($2.80) per share for the quarter.

Mainz Biomed Trading Down 1.4%

Shares of MYNZ stock opened at $1.38 on Friday. The firm’s 50-day simple moving average is $2.26 and its 200-day simple moving average is $3.93. The firm has a market cap of $4.75 million, a P/E ratio of -0.02 and a beta of 0.30. Mainz Biomed has a 1-year low of $1.34 and a 1-year high of $22.40. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.32 and a quick ratio of 1.26.

Mainz Biomed Company Profile

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer.